{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:15:29Z","timestamp":1772608529697,"version":"3.50.1"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Assessment of drug susceptibility has become an integral part of influenza virus surveillance. In this study, we describe the drug resistance profile of influenza A(H3N2) virus, A\/Mississippi\/05\/2011, collected from a patient treated with oseltamivir and detected via surveillance. An MDCK cell-grown isolate of this virus exhibited highly reduced inhibition by the neuraminidase (NA) inhibitors (NAIs) oseltamivir (8,005-fold), zanamivir (813-fold), peramivir (116-fold), and laninamivir (257-fold) in the NA inhibition assay. Sequence analysis of its NA gene revealed a known oseltamivir-resistance marker, the glutamic acid-to-valine substitution at position 119 (E119V), and an additional change, threonine to isoleucine at position 148 (T148I). Unlike E119V, T148I was not detected in the clinical sample but acquired during viral propagation in MDCK cells. Using recombinant proteins, T148I by itself was shown to cause only a 6-fold increase in the zanamivir 50% inhibitory concentration (IC\n            <jats:sub>50<\/jats:sub>\n            ) and had no effect on inhibition by other drugs. The T148I substitution reduced NA activity by 50%, most likely by affecting the positioning of the 150 loop at the NA catalytic site. Using pyrosequencing, changes at T148 were detected in 35 (23%) of 150 MDCK cell-grown A(H3N2) viruses tested, which was lower than the frequency of changes at D151 (85%), an NA residue previously implicated in cell selection. We demonstrate that culturing of the A(H3N2) viruses (\n            <jats:italic>n<\/jats:italic>\n            = 11) at a low multiplicity of infection delayed the emergence of the NA variants with changes at position 148 and\/or 151, especially when conducted in MDCK-SIAT1 cells. Our findings highlight the current challenges in monitoring susceptibility of influenza A(H3N2) viruses to the NAI class of antiviral drugs.\n          <\/jats:p>","DOI":"10.1128\/aac.01364-13","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T05:19:19Z","timestamp":1380604759000},"page":"6141-6146","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":42,"title":["Cell Culture-Selected Substitutions in Influenza A(H3N2) Neuraminidase Affect Drug Susceptibility Assessment"],"prefix":"10.1128","volume":"57","author":[{"given":"Daisuke","family":"Tamura","sequence":"first","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Battelle Memorial Institute, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Sleeman","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marnie","family":"Levine","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"},{"name":"Battelle Memorial Institute, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliy P.","family":"Mishin","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Guo","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Okomo-Adhiambo","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyan","family":"Xu","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Stevens","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa V.","family":"Gubareva","sequence":"additional","affiliation":[{"name":"Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"Centers for Disease Control and Prevention. 2011. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 60:1\u201328. http:\/\/www.cdc.gov\/mmwr\/pdf\/rr\/rr6001.pdf."},{"key":"e_1_3_3_3_2","volume-title":"WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. 2010. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/h1n1_guidelines_pharmaceutical_mngt.pdf."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2009.171462"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2067"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9892"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(93)90036-Q"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.1.250"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.8.5519-5524.1996"},{"key":"e_1_3_3_10_2","first-page":"398","article-title":"Specific biochemical features of replication of clinical influenza viruses in human intestinal cell culture","volume":"72","author":"Zhirnov OP","year":"2007","unstructured":"ZhirnovOP VorobjevaIV SaphonovaOA MalyshevNA OvcharenkoAV KlenkHD. 2007. Specific biochemical features of replication of clinical influenza viruses in human intestinal cell culture. Biochemistry 72:398\u2013408.","journal-title":"Biochemistry"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2009.05.030"},{"key":"e_1_3_3_12_2","first-page":"65","article-title":"Cell culture for surveillance on influenza","volume":"98","author":"Zambon M","year":"1999","unstructured":"ZambonM. 1999. Cell culture for surveillance on influenza. Dev. Biol. Stand. 98:65\u201374.","journal-title":"Dev. Biol. Stand."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.9.2.175-179.1979"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/am.16.4.588-594.1968"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.7.1900-1901.1997"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.4.3357-3362.1997"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/440435a"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.1.78-87.2000"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/314440"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1654(200001\/02)10:1<45::AID-RMV265>3.0.CO;2-R"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8418-8425.2003"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.8.4139-4146.2005"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00398-08"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00458-10"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01426-12"},{"key":"e_1_3_3_26_2","volume-title":"Manual for the laboratory diagnosis and virological surveillance of influenza","author":"WHO Global Influenza Surveillance Network","year":"2011","unstructured":"WHO Global Influenza Surveillance Network. 2011. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO, Geneva, Switzerland. http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241548090_eng.pdf."},{"key":"e_1_3_3_27_2","first-page":"33","volume-title":"Virology methods manual","author":"Hierholzer JC","year":"1996","unstructured":"HierholzerJC KillingtonRA. 1996. Virus isolation and Quantification: detection of viruses in cell cultures in absence of CPE, p 33\u201335. In MahyBVJ KangroHO (ed), Virology methods manual. Academic Press, San Diego, CA."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12113"},{"key":"e_1_3_3_29_2","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012","volume":"87","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. 2012. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012. Wkly. Epidemiol. Rec. 87:369\u2013374.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02424-10"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.08.008"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01200-09"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.11.005"},{"key":"e_1_3_3_34_2","first-page":"21","article-title":"Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses","volume":"85","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. 2010. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly. Epidemiol. Rec. 85:21\u201328.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.suppl_2.17"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2008.07.017"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01364-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01364-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:29:05Z","timestamp":1645482545000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01364-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1128\/AAC.01364-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.01364-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"2013-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-09-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-11-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}